<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>AmitisGen TECH Dev Group</PublisherName>
				<JournalTitle>Personalized and Precision Medicine Journal</JournalTitle>
				<Issn>3115-7874</Issn>
				<Volume>11</Volume>
				<Issue>41</Issue>
				<PubDate PubStatus="epublish">
					<Year>2026</Year>
					<Month>06</Month>
					<Day>30</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Circulating miR-21-5p as a Diagnostic Biomarker in Colorectal Cancer: Clinical Evaluation and Integrated Bioinformatics Analysis of Its Molecular Targets</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>54</FirstPage>
			<LastPage>63</LastPage>
			<ELocationID EIdType="pii">738541</ELocationID>
			
<ELocationID EIdType="doi">10.22034/ppmj.2026.738541</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Farnoosh</FirstName>
					<LastName>Honarmand</LastName>
<Affiliation>Department of Biology, Faculty of Basic Sciences, Tehran Branch, University of Science and Culture, Tehran, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Mahnaz</FirstName>
					<LastName>Saremi</LastName>
<Affiliation>Reference Health Laboratory, Ministry of Health and Medical Education, Tehran, Iran.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2026</Year>
					<Month>02</Month>
					<Day>17</Day>
				</PubDate>
			</History>
		<Abstract>Background: Circulating microRNAs have emerged as promising minimally invasive biomarkers for colorectal cancer (CRC). This study evaluated the expression and diagnostic performance of circulating hsa-miR-21-5p and investigated its potential molecular targets using integrated bioinformatics analysis.&lt;br&gt;Methods: Plasma samples were obtained from 50 treatment-naïve male patients with histologically confirmed grade II CRC and 20 healthy male controls. Circulating RNA was extracted and miR-21-5p expression was quantified using stem-loop reverse transcription quantitative PCR. Hsa-miR-1228-3p was used as the endogenous reference, and relative expression was calculated using the 2^−ΔΔCq method. Diagnostic performance was assessed by receiver operating characteristic analysis. High-confidence target genes were identified using miRDB and TargetScan, followed by protein–protein interaction analysis using STRING.&lt;br&gt;Results: The mean ages of patients and controls were 55 and 49 years, respectively, with no significant between-group difference (P=0.162). Circulating miR-21-5p expression was significantly higher in CRC patients than in healthy controls (P=0.002). ROC analysis yielded an area under the curve of 0.873 (95% CI, 0.766–0.979; P&lt;0.0001). Target prediction identified a set of high-confidence genes involved in cell proliferation, apoptosis, immune regulation, adhesion, extracellular-matrix organization, and transcriptional control. STRING analysis revealed a functionally connected network containing central signaling proteins, including STAT3, YAP1, SKP2, PDCD4, TRAF6, and SPRY-family proteins.&lt;br&gt;Conclusion: Circulating miR-21-5p demonstrated good ability to distinguish CRC patients from healthy controls. The bioinformatics findings suggest that its biological effects may involve interconnected oncogenic, apoptotic, immune, and invasion-related pathways.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Colorectal cancer, Circulating microRNA, miR-21-5p, Liquid biopsy, Protein&amp;ndash</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Protein Interaction</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.pmjournal.ir/article_738541_54805fcc3e9cf7760f1fc9334c3be4dc.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
